Kai Blöndal

Kai Blöndal

UNVERIFIED PROFILE

Are you Kai Blöndal?   Register this Author

Register author
Kai Blöndal

Kai Blöndal

Publications by authors named "Kai Blöndal"

Are you Kai Blöndal?   Register this Author

5Publications

141Reads

7Profile Views

Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert Mycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube.

Microb Drug Resist 2017 Dec 27;23(8):1045-1052. Epub 2017 Apr 27.

2 Department of Pulmonary Medicine, University of Tartu , Tartu, Estonia .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/mdr.2016.0149DOI Listing
December 2017

[Multidrug resistant tuberculosis in Iceland--case series and review of the literature].

Laeknabladid 2009 Jul-Aug;95(7-8):499-507

Smitsjúkdómadeild Landspítala Fossvogi, Reykavík.

View Article

Download full-text PDF

Source
August 2009

Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis.

Authors:
Kai Blöndal

Bull World Health Organ 2007 May;85(5):387-90; discussion 391-4

KNCV TF, Hjardarhagi, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636665PMC
http://dx.doi.org/10.2471/06.035345DOI Listing
May 2007